Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

KaloBios Pharmaceuticals Inc (OTC Pink - Limited Information:KBIO)

3.50
Delayed Data
As of Sep 23
 0.00 / 0.00%
Today’s Change
0.44
Today|||52-Week Range
45.82
-85.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues6.1M44.0K0.000.00
 
 
 
Depreciation And Amortization304.0K298.0K310.0K197.0K
 
 
 
 
 
 
Operating ExpensesGross Income5.8M---310.0K-197.0K
 
 
 
 
General Expenses29.3M40.7M36.4M28.6M
 
 
 
 
 
Research And Development24.5M32.6M26.6M15.6M
 
 
 
 
 
Total Operating Expenses29.6M41.0M36.7M28.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.5M-40.9M-36.7M-28.8M
 
 
 
 
 
Extraordinary Charge-39.0K0.000.00-5.8M
 
 
 
Interest Expense On Debt185.0K1.1M1.2M842.0K
 
 
 
 
 
Other Expenses152.0K-39.0K-154.0K39.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.5M-41.9M-38.0M-35.4M
 
 
 
 
 
Net Income-23.5M-41.9M-38.0M-35.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS262.0K3.0M4.1M4.1M
 
 
 
 
 
Shares To Calculate EPS Diluted262.0K3.0M4.1M4.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$89.76-$13.84-$9.20-$8.57
 
 
 
 
 
EPS Diluted-$89.76-$13.84-$9.20-$8.58